Language of Resource
Full Text Available
Open Access / OK to Reproduce
We conducted a qualitative systematic review to synthesize the evidence on providers’ experiences with relaxing restrictions on take-home doses of medications prescribed for opioid use disorder during the COVID-19 pandemic.
Our findings support the continuation of flexibilities around take-homes and demonstrate that regulations and policies that reduce flexibility around take-homes conflict with person-centered approaches to care.
Lit review (13 articles included, representing 11 studies)